Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Onur Baser

Showing results (41-50 of 156) with videos related to

Pageof 16
Sort By:
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|July 11, 2018
Alvimopan, Regardless of Ileus Risk, Significantly Impacts Ileus, Length of Stay, and Readmission After Intestinal SurgeryAhmed M Al-Mazrou, Onur Baser, Ravi P Kiran
Leukemia & Lymphoma|June 26, 2018
Costs of relapsed diffuse large B-cell lymphoma among Medicare patientsScott Huntington, Allison Keshishian, Michael McGuire, et al.
Current Medical Research and Opinion|January 4, 2011
Clinical and cost outcomes of venous thromboembolism in Medicare patients undergoing total hip replacement or total knee replacement surgeryOnur Baser, Dylan Supina, Nishan Sengupta, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|August 20, 2010
Impact of postoperative venous thromboembolism on Medicare recipients undergoing total hip replacement or total knee replacement surgeryOnur Baser, Dylan Supina, Nishan Sengupta, et al.
Journal of Diabetes Science and Technology|May 31, 2014
Does Device Make Any Difference? A Real-world Retrospective Study of Insulin Treatment Among Elderly Patients With Type 2 DiabetesRaymond Miao, Wenhui Wei, Jay Lin, et al.
Advances in Therapy|November 1, 2011
A real-world study of patients with type 2 diabetes initiating basal insulins via disposable pensLin Xie, Wenhui Wei, Chunshen Pan, et al.
Journal of Medical Economics|June 30, 2016
Comparative persistence and adherence with newer anti-hyperglycemic agents to treat patients with type 2 diabetes in the United StatesJennifer Cai, Yuexi Wang, Onur Baser, et al.
Journal of Managed Care & Specialty Pharmacy|June 29, 2018
Evaluating the Effect of Treatment Persistence on the Economic Burden of Moderate to Severe Psoriasis and/or Psoriatic Arthritis Patients in the U.S. Department of Defense PopulationSeina Lee, Lin Xie, Yuexi Wang, et al.
BMJ Open|May 2, 2013
Real-world outcomes of US employees with type 2 diabetes mellitus treated with insulin glargine or neutral protamine Hagedorn insulin: a comparative retrospective database studyLi Wang, Wenhui Wei, Raymond Miao, et al.
Clinical Therapeutics|May 23, 2015
Impact of Switching From an Initial Tumor Necrosis Factor Inhibitor on Health Care Resource Utilization and Costs Among Patients With Rheumatoid ArthritisOnur Baser, Arijit Ganguli, Sanjoy Roy, et al.
Pageof 16

Showing results (41-50 of 156) with videos related to

Sort By:
Pageof 16
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|July 11, 2018
Alvimopan, Regardless of Ileus Risk, Significantly Impacts Ileus, Length of Stay, and Readmission After Intestinal SurgeryAhmed M Al-Mazrou, Onur Baser, Ravi P Kiran
Leukemia & Lymphoma|June 26, 2018
Costs of relapsed diffuse large B-cell lymphoma among Medicare patientsScott Huntington, Allison Keshishian, Michael McGuire, et al.
Current Medical Research and Opinion|January 4, 2011
Clinical and cost outcomes of venous thromboembolism in Medicare patients undergoing total hip replacement or total knee replacement surgeryOnur Baser, Dylan Supina, Nishan Sengupta, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|August 20, 2010
Impact of postoperative venous thromboembolism on Medicare recipients undergoing total hip replacement or total knee replacement surgeryOnur Baser, Dylan Supina, Nishan Sengupta, et al.
Journal of Diabetes Science and Technology|May 31, 2014
Does Device Make Any Difference? A Real-world Retrospective Study of Insulin Treatment Among Elderly Patients With Type 2 DiabetesRaymond Miao, Wenhui Wei, Jay Lin, et al.
Advances in Therapy|November 1, 2011
A real-world study of patients with type 2 diabetes initiating basal insulins via disposable pensLin Xie, Wenhui Wei, Chunshen Pan, et al.
Journal of Medical Economics|June 30, 2016
Comparative persistence and adherence with newer anti-hyperglycemic agents to treat patients with type 2 diabetes in the United StatesJennifer Cai, Yuexi Wang, Onur Baser, et al.
Journal of Managed Care & Specialty Pharmacy|June 29, 2018
Evaluating the Effect of Treatment Persistence on the Economic Burden of Moderate to Severe Psoriasis and/or Psoriatic Arthritis Patients in the U.S. Department of Defense PopulationSeina Lee, Lin Xie, Yuexi Wang, et al.
BMJ Open|May 2, 2013
Real-world outcomes of US employees with type 2 diabetes mellitus treated with insulin glargine or neutral protamine Hagedorn insulin: a comparative retrospective database studyLi Wang, Wenhui Wei, Raymond Miao, et al.
Clinical Therapeutics|May 23, 2015
Impact of Switching From an Initial Tumor Necrosis Factor Inhibitor on Health Care Resource Utilization and Costs Among Patients With Rheumatoid ArthritisOnur Baser, Arijit Ganguli, Sanjoy Roy, et al.
Pageof 16